<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17191">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883088</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-01-2013</org_study_id>
    <nct_id>NCT02883088</nct_id>
  </id_info>
  <brief_title>Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome</brief_title>
  <acronym>CLIMA</acronym>
  <official_title>Relationship Between Coronary Plaque Morphology of Left Anterior Descending Artery and Long Term Clinical Outcome: the CLIMA Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Giovanni Addolorata Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centro per la Lotta contro l’Infarto – Fondazione Onlus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>San Giovanni Addolorata Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The multicenter observational CLIMA registry has been conceived to explore correlation
      between OCT morphology of atherosclerotic plaques located in the left anterior descending
      artery with mid and long term clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute myocardial infarction (MI) is commonly caused by plaque ulceration and subsequent
      local thrombosis. Plaques that tend to rupture are typically characterized by a large
      superficial lipid pool, delimited by a thin fibrous cap and often exhibit local signs of
      inflammation. Such atherosclerotic lesions are commonly described as vulnerable plaques
      (1-4).

      Identification of these plaque features with imaging modalities is potentially a valid
      approach to identify patients at increased risk of M (5). Optical coherence tomography is
      capable of visualizing superficial plaque components at a high resolution (in the range of
      10-15 microns) and can depict all the features of plaque vulnerability or thrombogenicity
      (6,7).

      The aim of the study is to relate presence of multiple OCT criteria of plaque vulnerability
      with following clinical events in a subset of coronary lesions. For this purpose all plaques
      in the proximal-mid portion of the left anterior descending artery will be evaluated with
      FD-OCT assessing the following criteria:

        -  minimum lumen area (MLA) &lt;4 mm2:

        -  fibrous cap minimum thickness &lt;65 µm:

        -  lipid arc extension &gt;180°;

        -  presence of macrophages;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>1-year</time_frame>
    <description>Composite of cardiac death and/or target vessel myocadial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>3-year</time_frame>
    <description>Composite of cardiac death and/or target vessel myocadial infarction</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Predictive value of single OCT criteria of plaque vulnerability</measure>
    <time_frame>1-year and 3-year</time_frame>
    <description>Predictive value of minimum lumen area, fibrous cap thickness, lipid arc extension, presence of macrophages at the explored plaques</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>LAD-group</arm_group_label>
    <description>Subjects over 18 years who are undergoing Frequency Domain - Optical Coherence Tomography (FD-OCT) evaluation of the native left anterior descending artery during clinically indicated coronary angiography regardless of the clinical syndrome (silent ischemia, effort angina or acute coronary syndrome).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Frequency Domain - Optical Coherence Tomography (FD-OCT)</intervention_name>
    <description>FD-OCT assessment of the native proximal-mid left descending artery during clinically indicated coronary angiography</description>
    <arm_group_label>LAD-group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive subjects undergoing OCT assessment of the proximal left descending artery
        coronary during coronary angiography should be screened for eligibility.

        Patients will be enrolled from participating centers at the time of OCT assessment and
        prospectively investigated to evaluate clinical outcome.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years;

          -  Patients with clinical indication to coronary angiography undergoing OCT evaluation
             of the left anterior descending artery regardless of the clinical syndrome;

          -  Patients with at least 30 mm of naïve OCT-assessable proximal-mid left anterior
             descending artery;

          -  Patient has been informed of the nature of the study and agrees to its provisions and
             has provided written informed consent to the procedure;

        Exclusion Criteria:

          -  Female with childbearing potential or lactating;

          -  Acute or chronic renal dysfunction (defined as creatinine greater than 2.0 mg/dl);

          -  Advanced heart failure (NYHA III-IV)

          -  Previous Coronary artery by-pass surgery

          -  Previous stenting of proximal-mid left anterior descending artery with residual
             untreated segment &lt;30mm.

          -  Co-morbidities that could interfere with completion of study procedures, or life
             expectancy less than 1 year;

          -  Participating in another investigational drug or device trial that has not completed
             the primary endpoint or would interfere with the endpoints of this study;

          -  Heavily calcified vessel and/or lesion which cannot be successfully imaged by OCT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Prati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Giovanni Addolorata Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Prati, MD</last_name>
    <phone>+390677208915</phone>
    <email>fprati@hsangiovanni.roma.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valeria Marco, RT</last_name>
    <phone>+390677208915</phone>
    <email>euroimagingroma@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Policlinico Sant'Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Saia, MD</last_name>
      <email>francescosaia@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Francesco Saia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nevio Taglieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Brotzu</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Boi, MD</last_name>
      <email>albeboi@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Alberto Boi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Sant'Elia</name>
      <address>
        <city>Caltanissetta</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Amico, MD</last_name>
      <email>famico64@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Francesco Amico, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Catania</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessio La Manna, MD</last_name>
      <email>lamanna.cardio@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Corrado Tamburino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessio La Manna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GVM Care and Research, E. S. Health Science Foundation</name>
      <address>
        <city>Cotignola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fausto Castriota, MD</last_name>
      <email>fcastriota@msn.com</email>
    </contact>
    <investigator>
      <last_name>Fausto Castriota, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Micari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Misericordia Hospital</name>
      <address>
        <city>Grosseto</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ugo Limbruno, MD</last_name>
      <email>ulimbru@tin.it</email>
    </contact>
    <investigator>
      <last_name>Ugo Limbruno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Picchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Ferdinando Veneziale</name>
      <address>
        <city>Isernia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Versaci, MD</last_name>
      <email>francescoversaci@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Versaci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Trivisonno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico G. Martino</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Di Giorgio, MD</last_name>
      <email>alexdigiorgio@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Di Giorgio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino IRCCS</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Fabbiocchi, MD</last_name>
      <email>Franco.Fabbiocchi@ccfm.it</email>
    </contact>
    <investigator>
      <last_name>Franco Fabbiocchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Giovanni-Addolorata Hospital</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Prati, MD</last_name>
      <phone>+390677208915</phone>
      <email>fprati@hsangiovanni.roma.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Prati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Gatto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Cattolica Del Sacro Cuore</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Burzotta, MD</last_name>
      <email>francescoburzotta@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carlo Trani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Burzotta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Umberto I°</name>
      <address>
        <city>Siracusa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Contarini, MD</last_name>
      <email>marcocontarini@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marco Contarini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giorgio Sacchetta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital of the Ministry of Interior</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Gil, MD</last_name>
      <email>robert.gil@cskmswia.pl</email>
    </contact>
    <investigator>
      <last_name>Tomasz Pawlowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Gil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Alfonso, MD</last_name>
      <email>falf@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Fernando Alfonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995 Aug 1;92(3):657-71. Review.</citation>
    <PMID>7634481</PMID>
  </reference>
  <reference>
    <citation>De Caterina R. Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Clin Nutr Metab Care. 2000 Nov;3(6):453-67. Review.</citation>
    <PMID>11085831</PMID>
  </reference>
  <reference>
    <citation>Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 7;108(14):1664-72. Review.</citation>
    <PMID>14530185</PMID>
  </reference>
  <reference>
    <citation>Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, Malik S, Fuster V, Finn AV. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013 Mar 12;61(10):1041-51. doi: 10.1016/j.jacc.2012.10.054.</citation>
    <PMID>23473409</PMID>
  </reference>
  <reference>
    <citation>Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz HT, Tearney GJ. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002 Feb 20;39(4):604-9.</citation>
    <PMID>11849858</PMID>
  </reference>
  <reference>
    <citation>Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005 Mar 29;111(12):1551-5. Epub 2005 Mar 21.</citation>
    <PMID>15781733</PMID>
  </reference>
  <reference>
    <citation>Kawasaki M, Bouma BE, Bressner J, Houser SL, Nadkarni SK, MacNeill BD, Jang IK, Fujiwara H, Tearney GJ. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol. 2006 Jul 4;48(1):81-8. Epub 2006 Jun 9.</citation>
    <PMID>16814652</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 25, 2016</lastchanged_date>
  <firstreceived_date>August 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Giovanni Addolorata Hospital</investigator_affiliation>
    <investigator_full_name>Francesco Prati</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Optical coherence tomograhpy</keyword>
  <keyword>registry</keyword>
  <keyword>Coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
